Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Filings indexed 975 across all filing types
Latest filing 2026-05-07 Declaration of Voting R…
Country FR France
Listing PA FR000

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : Declaration of the number of shares and voting rights 04/2026
Declaration of Voting Results & Voting Rights Announcements
2026-05-07 English
Virbac : Déclaration d'actions et de droits de vote 04/2026
Declaration of Voting Results & Voting Rights Announcements
2026-05-07 French
Virbac : Communiqué de mise à disposition du Rapport Annuel de Virbac au 31 décembre 2025
Report Publication Announcement Classification · 91% confidence The document is a short notice informing that the Annual Report for the year ended 31 December 2025 has been made available and filed with the AMF, with links to download the PDF and XBRL versions. It does not contain the report itself or financial details, but rather announces its publication. Under the “menu vs meal” rule, such a brief publication notice is classified as a Report Publication Announcement (RPA).
2026-04-27 French
Virbac : Rapport Annuel Virbac au 31 décembre 2025 (ESEF)
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-04-27 French
Virbac : Public release of Virbac Annual Report at 31 December 2025.
Report Publication Announcement Classification · 92% confidence The document is a short announcement stating that Virbac has released and filed its 2025 Annual Report with the French regulator, noting that the report is attached and available on the corporate website. It does not contain the full annual report itself but merely informs investors of its publication. Under the “menu vs meal” rule, this is a Report Publication Announcement.
2026-04-27 English
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms
Earnings Release Classification · 92% confidence The document is a press release detailing Virbac’s first-quarter 2026 revenue figures, growth rates, segment performance, and guidance. It presents high-level financial highlights and CEO commentary typical of an initial quarterly earnings announcement rather than a full interim report or investor presentation. Therefore, it is classified as an Earnings Release. Q1 2026
2026-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.